AmericasDevelopingDay 2
Bayer Roundup cancer settlement approval
Bayer's share price has fallen 46% since its $63bn Monsanto purchase in 2018, and it settled much of the Roundup litigation for $10.9bn in 2020.
Updated 17:15 UTC, 21 November 2026 · 3 reports from 3 outlets · 2 confirmed · 13 one-source
Top reportUS court greenlights Bayer’s $7.25 bn Roundup cancer deal

Image: RT
Read it your way
Loading the summary…
Written by AI only from the receipts on this page; each number links to the claim that line rests on.
What changed
Last 48 hours, newest first (times UTC)
-
Where it stands Bayer's share price has fallen 46% since its $63bn Monsanto purchase in 2018, and it settled much of the Roundup litigation for $10.9bn in 2020.
9 earlier changes
-
Story opened A US judge has approved Bayer's $7.25bn settlement of claims that its Roundup weedkiller causes cancer.
How it’s being told
One card per media bloc, with each outlet’s framing written from its own headlines.
Russian state media
RTState media
- RT foregrounds the court's approval of Bayer's '$7.25 bn Roundup cancer deal' and the WHO's 'probably carcinogenic' classification, centring the litigation's legal and health stakes while noting the.
European media
Financial TimesPrivateThe GuardianNon-profit
- The Financial Times centres the US judge's approval of Bayer's '$7.25bn settlement over cancer cases', foregrounding the legal outcome and sum while omitting the state line's context on.
- The Guardian centres the judge's approval of a '$7.25bn Bayer payout' and the litigation history behind it, foregrounding Bayer's CEO calling the approval a 'decisive milestone' while noting.
In their words
What the people at the centre of this story said, word for word, with the article each quote appeared in.
The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation
Receipts
Every claim with the verbatim sentence it came from. Tap a claim to see its sources.
Confirmed 2
Reported by at least two independent outlets, or by the actor itself.
Bayer settled much of the Roundup litigation for $10.9bn in 2020.
-
“The company agreed to a $10.9 billion settlement in 2020, has spent at least $14 billion on Roundup litigation, and set aside around $16 billion for related legal costs.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
-
“The company settled much of the Roundup litigation for $10.9bn in 2020, but was unable to win court approval of a $1.25bn settlement to resolve future Roundup claims.”
The GuardianNon-profitReportsJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
Bayer's share price has fallen 46% since it bought Monsanto for $63bn in 2018.
-
“Its shares have fallen around 46% since the Monsanto takeover.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
-
“Bayer has faced extensive litigation over Roundup, and had seen its share price fall 46% since it bought Monsanto, which produces the weedkiller, for $63bn in 2018.”
The GuardianNon-profitReportsJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
One source 13
Only one outlet so far. Shown, never hidden — treat with care.
The World Health Organization's cancer research agency classified glyphosate as 'probably carcinogenic' in 2015.
-
“The World Health Organization’s cancer research agency classified glyphosate as ‘probably carcinogenic’ in 2015.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
Around 200 cases remain pending in federal courts outside the settlement.
-
“Despite the ruling on Friday, around 200 cases remain pending in federal courts outside the settlement.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
Bayer set aside around $16 billion for related legal costs.
-
“The company agreed to a $10.9 billion settlement in 2020, has spent at least $14 billion on Roundup litigation, and set aside around $16 billion for related legal costs.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
Bayer has spent at least $14 billion on Roundup litigation.
-
“The company agreed to a $10.9 billion settlement in 2020, has spent at least $14 billion on Roundup litigation, and set aside around $16 billion for related legal costs.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
The US Supreme Court restricted lawsuits under state laws requiring additional cancer warnings in June.
-
“In June, the US Supreme Court restricted lawsuits under state laws requiring additional cancer warnings, paving the way for approval.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
Bayer reached a preliminary settlement in February after years of litigation.
-
“After years of litigation, Bayer reached a preliminary settlement in February.”
RTState mediaReportsUS court greenlights Bayer’s $7.25 bn Roundup cancer deal
The US supreme court overturned a $1.25m jury award for Missouri man John Durnell, who blamed Roundup exposure for his non-Hodgkin lymphoma.
-
“The settlement was approved five months after the US supreme court overturned a $1.25m jury award for a Missouri man, John Durnell, who blamed years of exposure to glyphosate in Roundup for his non-Hodgkin lymphoma.”
The GuardianNon-profitReportsJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
Bayer CEO Bill Anderson called the court's final approval a decisive milestone in the company's strategy to mitigate Roundup litigation risks.
-
““The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” Bayer’s CEO, Bill Anderson, said in a statement.”
The GuardianNon-profitAttributesJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
Bayer announced the Roundup settlement in February.
-
“The settlement announced in February aimed to resolve nearly all current and future Roundup claims in the US.”
The GuardianNon-profitReportsJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
Bayer faced approximately 65,000 claims from people who said they developed cancer after using Roundup.
-
“Bayer had faced approximately 65,000 claims in US state and federal courts from people who said they developed cancer after using Roundup at home or on the job.”
The GuardianNon-profitReportsJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
Judge Timothy Boyer found the Roundup settlement fair, reasonable and adequate.
-
“Judge Timothy Boyer of a state court in St Louis found the settlement “fair, reasonable and adequate”.”
The GuardianNon-profitReportsJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
A Missouri judge approved Bayer's $7.25bn settlement of lawsuits alleging Roundup causes cancer on Friday.
-
“A Missouri judge on Friday approved Bayer’s $7.25bn settlement of lawsuits alleging that its weedkiller Roundup causes cancer, potentially resolving litigation that has weighed on the German company for close to a decade.”
The GuardianNon-profitReportsJudge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
A US judge approved Bayer's $7.25bn settlement over cancer cases.
-
“Bayer’s $7.25bn settlement over cancer cases approved by US judge”
Financial TimesPrivateReportsBayer’s $7.25bn settlement over cancer cases approved by US judge
Ask about this story
Line, our AI correspondent, answers only from the receipts on this page. Every sentence links to the claim behind it.
All sources
3 reports from 3 outlets — with who owns each outlet and who pays for it.
RT State media
RussiaOwner: ANO TV-NovostiPaid by: Russian federal budget
Financial Times Private
United KingdomOwner: Nikkei Inc.Paid by: subscriptions + advertising
The Guardian Non-profit
United KingdomOwner: Guardian Media Group, owned by the Scott Trust LimitedPaid by: reader contributions + subscriptions + advertising; Scott Trust endowment
Not covered yet by
Al JazeeraAssociated PressBBCCGTNCNADWEuronewsForeign PolicyFox NewsFrance 24NPRReutersSky NewsSouth China Morning PostSputnikTASSTRT WorldThe New York TimesThe Times of IndiaWION
Outlets we monitor that have not reported this story. Silence can be signal.
From the Faultline desk
Our analysis pieces on this story.
- NASA Turns to Students for the Hard Problems of Living on the Moon
- A Princess, a Diagnosis and a Film: Catherine Speaks on Cancer
- Bayer's $7.25bn Roundup Settlement Clears Court, Closing a Long Chapter
- Putin Says West Has Paralysed WTO Dispute Settlement
- Zverev Served with Lawsuit Mid-Tournament as Legal Fight Intensifies
2 confirmed · 13 one-source3 outletsUpdated